| Jamie Bates |
Gilead |
| Lee Borthwick |
Newcastle University |
| David Brenner |
University of California San Diego |
| Grant Budas |
GILEAD |
| Karim Dabbagh |
Second Genome |
| Milena Espindola |
Cedars-Sinai Medical Center |
| Thomas Fabre |
Pfizer |
| Federica Genovese |
NORDIC BIOSCIENCE A/S |
| Kevin Hart |
Pfizer |
| Neil Henderson |
University of Edinburgh |
| Boris Hinz |
University of Toronto |
| Wolfgang Jarolimek |
Pharmaxis Ltd. |
| Gisli Jenkins |
Imperial College London |
| Tatiana Kisseleva |
University of California San Diego |
| Rafael Kramann |
RWTH Aachen University |
| Paul Martin |
University of Bristol |
| Fiona Oakley |
Newcastle University |
| Karen Piper-Hanley |
Manchester University |
| Yuval Rinkevich |
Helmholtz Zentrum Muenchen |
| Fabio Rossi |
University of British Columbia |
| Rebekka Schneider-Kramann |
Universitätsklinikum Aachen |
| Robert Schwabe |
Columbia University |
| James Trevaskis |
Gilead |
| Daniel Tschumperlin |
Mayo Clinic |
| Ludovic Vallier |
MRC Cambridge Stem Cell Institute |
| Sabine Werner |
Swiss Federal Institute of Technology (ETH) Zurich |
| Paul Yaworsky |
Mediar Therapeutics |
